Clinical Trials
All Clinical Trials - Page 41 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06473259N/ARecruiting
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
Gonadorelin
- NCT03054168Phase 3Unknown
Systemic Hormones and Muscle Protein Synthesis
Gonadorelin
- NCT02949362Phase 3Completed
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
Teduglutide
- NCT02972645Phase 1Completed
A Study of LY3305677 in Healthy Participants
Mazdutide
- NCT02973321Phase 2Completed
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT02976038Phase 2Terminated
Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
Elamipretide
- NCT02940535N/AUnknown
Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response
Gonadorelin
- NCT02324998Phase 1Completed
Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy
Gonadorelin
- NCT02973100Phase 2Completed
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
Dulaglutide
- NCT03017352Phase 2Completed
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
Exenatide
- NCT03002428Phase 3Completed
A Comparison of PF708 and Forteo in Osteoporosis Patients
Teriparatide
- NCT02970942Phase 2Completed
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
Semaglutide
- NCT02941926Phase 3Completed
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
Gonadorelin
- NCT02799602Phase 3Completed
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer
Gonadorelin
- NCT02856048Phase 2/Phase 3Unknown
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Gonadorelin
- NCT04292548N/ACompleted
Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children
Ll-37
- NCT03182296N/AUnknown
Visualizing Beta Cells in Patients With a History of Gestational Diabetes
Exenatide
- NCT02962492N/ACompleted
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
Exenatide
- NCT03735537Phase 4Completed
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
Teriparatide
- NCT02974907Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
TB-500
- NCT02976740Phase 2Unknown
SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
Thymosin-Alpha-1
- NCT03639376N/ACompleted
Passive Smoking and LL-37 in Children
Ll-37
- NCT02931383Phase 4Completed
Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Liraglutide
- NCT02928679Phase 4Completed
Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Liraglutide
- NCT02905864Phase 4Completed
Liraglutide 3 mg for Knee Osteoarthritis
Liraglutide
- NCT02928614Phase 4Completed
Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Liraglutide
- NCT02879409N/AActive Not Recruiting
HbA1c Variability in Type II Diabetes
Liraglutide
- NCT02931344N/AUnknown
Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
Liraglutide
- NCT02954627N/ACompleted
Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects; Weight Loss
Liraglutide
- NCT02910570Phase 4Completed
Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis
Liraglutide
- NCT02928471N/ACompleted
Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
Liraglutide
- NCT02944500Phase 4Active Not Recruiting
Saxenda: Underlying Mechanisms and Clinical Outcomes
Liraglutide
- NCT02931370N/ACompleted
Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
Liraglutide
- NCT02973204N/ACompleted
Circulating Tumor Cells and Tumor DNA in HCC and NET
Octreotide
- NCT02848313Phase 1Completed
An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
Elamipretide
- NCT03096847Phase 3Completed
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
Ghrp-6
- NCT02914665Phase 2Completed
A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure
Elamipretide
- NCT02770391Phase 2Completed
Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
Gonadorelin
- NCT03141632Phase 2Completed
Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
Dulaglutide
- NCT03182231Phase 1/Phase 2Unknown
GLP1-imaging Before and After Bariatric Surgery
Exenatide
- NCT02931474Phase 2Withdrawn
Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia
Tesamorelin
- NCT02889510Phase 3Completed
Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT02906163Phase 1/Phase 2Unknown
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
Thymosin-Alpha-1
- NCT02901379Phase 3Completed
Effect of 80-mg Atorvastatin on Myocardial Edema
Follistatin
- NCT02955056Phase 4Unknown
Ankle Fractures Treated With Teriparatide
Teriparatide
- NCT02874326Phase 2Unknown
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
Octreotide
- NCT02918279Phase 3Completed
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
Liraglutide
- NCT02793154Phase 4Terminated
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
Exenatide
- NCT02911948Phase 3Completed
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
Liraglutide
- NCT02849080Phase 3Completed
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
Semaglutide